PC Slower Than It Used to Be?
A free scan shows the junk files, broken settings and background clutter dragging Windows down - then fixes them in one click.Free scan · Windows 10 & 11Outdated Drivers Are Slowing You Down
One free scan finds every outdated or missing driver and matches the right update for your exact hardware.Free scan · exact hardware matchSpokane, Washington-based Gestalt Diagnostics announced a $7.5 million Series A on April 28, 2025. Cowles Ventures, TVF Funds (Tacoma Venture Fund), Inland Imaging Investments, KickStart Funds and Pacific Northwest angel investors participated. Gestalt says it will use the financing to expand customers, develop its artificial-intelligence capabilities, broaden deployment of its PathFlow platform and pursue FDA clearance.
The announcement confirms a significant commercialization round, not an FDA clearance or proof that Gestalt has created an autonomous cancer-diagnosis system. PathFlow is principally a digital-pathology workflow and image-management platform that can incorporate AI tools while keeping pathologists in control.
What Gestalt Diagnostics raised
Gestalt disclosed the $7.5 million Series A in its April 28, 2025 announcement. The company is headquartered in Spokane, Washington. The named investor group includes Cowles Ventures, TVF Funds, Inland Imaging Investments, KickStart Funds and Pacific Northwest angel investors. Gestalt’s announcement does not describe the round as the company’s total financing.
GeekWire, citing PitchBook, reported approximately $13.9 million in total funding, although third-party databases can differ in how they count prior financings. That figure should therefore be treated as an attributed estimate rather than a definitive company total. GeekWire’s report also describes the financing as intended to advance AI-enabled pathology.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
#1 Best Overall
- The Uniden BCD160DN sets the standard for performance, features, and innovation. Exclusive Features like Band Scope Rapid System/Channel Number Tagging, Narrow-band Reception, and a complete suite of search features help you detect those elusive signals faster than ever. Uniden Digital Scanners offer you more than ever before.
- DCS/CTCSS RAPID DECODE - Instantly detects and displays the sub audible tone so you can quickly determine the system settings. DMR - Included. NXDN - Included. 1,000 Channels. 'Trunking and APCO P25 not supported'.
- PRELOADED DMR/NXDN - The scanner comes preloaded with DMR and NXDN so you can start using your scanner as soon as you take it out of the box.
- CUSTOM SEARCH - Allows you to start searching at the displayed frequency or enter a frequency and start searching.
- PC PROGRAMMING - Use free available to download Uniden software to manage your scanner’s Profiles, Favorites Lists, Databases, and firmware updates.
What PathFlow actually does
Gestalt describes PathFlow as a vendor-neutral digital-pathology workflow and image-management platform. It is designed to bring whole-slide images, case and patient information, workflow routing, collaboration, AI applications and reporting into one environment.
Core use cases
- Anatomic-pathology and primary-diagnosis workflows.
- Remote and secondary consultation.
- Tumor boards and multidisciplinary review.
- Education and resident training.
- Research and clinical-trial work.
- Multi-site laboratory and health-system deployments.
The company says PathFlow can operate in cloud-based or on-premise configurations and is scanner-, laboratory-information-system- and AI-agnostic. It lists Anatomic Pathology, Education and Research modules. PathCloud, a web-based image-sharing and collaboration interface, and professional and IT services are also part of Gestalt’s broader offering. The company’s product overview describes those services and its AI portfolio.
How AI fits into the platform
“AI-enabled digital pathology” can mean several different things. In Gestalt’s case, the available product descriptions point to an operating and workflow layer that can integrate Gestalt-developed and third-party algorithms, rather than one general-purpose model that independently diagnoses every cancer.
- Glass slides are scanned into digital whole-slide images.
- Images and case data enter the laboratory’s configured workflow.
- Cases are routed to pathologists for review.
- Available AI applications can score biomarkers or highlight areas of interest.
- Pathologists review the images and any algorithmic output, collaborate and sign out cases.
- Data may also support education, research, clinical trials or drug-development projects.
The exact sequence varies by laboratory. AI findings are aids for professional review; “AI-enabled” does not establish that every algorithm is cleared for every tissue type, diagnosis or clinical setting.
Rank #2
- ON-THE-GO SCANNING MADE SIMPLE | Meet the Fastest, Lightest and Most Efficient Single Sheetfed Scanner in its Class. | The HPPS100 Mobile Document Scanner Lets You Convert Stacks of Papers Into Digital Files—No Heavy, Expensive Equipment Needed. | Wide Compatibility Makes it Easy to Send Docs and Images to Your PC or Mac Computer, Laptop, or Similar Windows/MacOS Devices for Amazing Versatility
- EASY, AFFORDABLE SIMPLEX SCANNING | Despite its Slim Profile, This Office Essential Offers Reliable 15ppm [15 Pages Per Minute or 4 Seconds Per Page] Operating Speed for Small- to Medium-Batch Jobs in Black and White and Color | Simplex One-Sided Scanning Technology Delivers Premium Results in a Single Pass, Speeding Up Scan Time and Improving Your Productivity When Converting Invoices, Contracts, Plans, Reports and Letters
- DESIGNED FOR LIGHTWEIGHT PORTABILITY | Slip Inside a Bag or Briefcase, Then Travel from Home to Office to Business and Beyond. | Compact, Portable Styling Suits Your Busy Lifestyle While Providing All the Capabilities of a Professional-Quality Document Scanner Including Beautiful 1200 dpi Resolution, Versatile Paper Size Ranging from 2” x 2.9” (Minimum) to 8.5” x 14” (Maximum) and Versatile Conversion to PDF, JPG and Other File Formats
- STUNNING SCANS WITHOUT THE BULK | Skip the Clunky, Messy, Complex Setups. | This Scanner Boasts a Tiny Footprint, Powers Via USB 2.0 [Cable Included] and Easily Plugs and Unplugs for Amazing On-the-Go Ease | Perfect Choice for People Who Fly or Travel for Work, Commuters, Small Business Owners, Legal Practices, Tax Preparers and Unique Scanning Tasks Such as Business Cards, Photos, Bills, Brochures, Receipts and Much More
- WORK SMARTER WITH HP WORKSCAN | Download Our Free, Easy-to-Use Software or App for Windows and MacOS to Start Scanning. | Simple, Intuitive Platform with Auto-Scan and Size Detection Allows You to Easily Adjust Document Settings; Preview and Zoom in on Scans; Crop, Edit and Optimize Image Quality; Clean Up Background, Edges and Holes; and Save to Destination with Just a Few Clicks—No Tech Savvy Required.
Why the company says the market needs this
Gestalt positions digital pathology as a response to increasing diagnostic workloads, fewer practicing pathologists in some regions, geographic barriers to specialist consultation and fragmented laboratory software. A shared digital image can be reviewed remotely, routed across sites and made available to multiple specialists without shipping glass slides.
Those are workflow and access arguments. The funding announcement’s statements about faster or more accurate diagnosis are company claims, not independent evidence of improved sensitivity, specificity, turnaround time or patient outcomes.
How Gestalt plans to use the $7.5 million
- Expand the customer base and broader market adoption.
- Enhance AI capabilities and integrations.
- Pursue FDA clearance.
- Increase scale and profitability.
- Potentially hire additional employees.
The Spokane Journal of Business reported on May 8, 2025 that Gestalt planned to hire but had not yet determined the number of positions. No public breakdown assigns the financing to engineering, sales, regulatory work or hiring. The regional report provides that local context.
Regulatory status: a planned milestone, not a confirmed clearance
Gestalt’s financing announcement says the capital will help it pursue FDA clearance. It does not say that PathFlow or a PathFlow AI function had already received FDA clearance.
Rank #3
- 【Convert Film to Digital at Home】 Easily scan 35mm (135), 126, 110 and Super 8 (photo only), including color and black & white negatives and slides. A versatile film, negative and slide scanner with no computer required
- 【16MP / 22MP High-Resolution Scans】 Choose between 16MP standard or enhanced 22MP output for sharper details and clearer images
- 【Large 5" LCD Screen for Instant Preview】 Preview, adjust and align photos in real time directly on the scanner for easy and accurate scanning
- 【Save to SD Card & HDMI Output】 Store photos directly to SD card up to 128GB or connect to a TV via HDMI for real-time viewing
- 【Built-In Image Adjustment Tools】 Adjust brightness, color and orientation to enhance image quality before saving your digital photos
The FDA’s product-code QKQ category covers digital-pathology image-viewing and management software and is generally a Class II device category. The agency’s database includes substantially equivalent decisions involving companies such as PathAI, Paige, PathPresenter, Tribun Health and Lumea. The FDA QKQ listing supplies category context, but the surfaced material does not establish a Gestalt-specific clearance.
That absence is not conclusive proof that Gestalt has never filed an application or used another regulatory pathway. It does mean readers should not describe the company as FDA-cleared based solely on the 2025 funding announcement.
Gestalt’s marketing materials reference HIPAA, SOC 2, ISO and CE-related compliance language. Those safeguards or conformity claims are not interchangeable with U.S. FDA clearance for a clinical diagnostic indication. The company’s PathFlow AP module sheet also says certain AI or diagnostic functions may be research use only unless used under applicable CAP laboratory-developed-test guidelines. The product sheet contains that qualification.
Traction reported after the financing
Gestalt’s news page lists several developments after the Series A:
Rank #4
- Stay Safe and Informed with the Uniden BCD996P2. A true scanner powerhouse, it comes with state-of-the-art NOAA weather access and S.A.M.E. weather alerts that warn you of severe conditions in your area. This mobile scanner radio comes with 25,000 channels, Close Call RF Capture, TrunkTracker V technology, and more.
- CLOSE CALL RF TECHNOLOGY WITH DND Provides information about nearby radio transmissions. Close Call Do-Not-Disturb checks for Close Call activity during channel reception so active channels are not interrupted.
- TRUNK TRACKER V OPERATION Scans APCO 25 Phase 1 and Phase 2, X2-TDMA, Motorola, EDACS, and LTR trunked systems, as well as conventional analog and P25 digital channels.
- S.A.M.E. WEATHER ALERT Stay ahead of the weather and on top of the waves. During an NOAA Weather or Emergency Alert, a code for your specific location will alert you to severe conditions in your immediate area.
- LOCATION BASED SCANNING Connect this scanner to a compatible GPS receiver and it will automatically select programmed systems based on your exact location. You'll save time by scanning only the local signals.
- PathFlow Version 6 was introduced on October 5, 2025.
- A Voicebrook integration was announced on August 12, 2025.
- Gestalt announced partnerships involving Tulsa Medical Laboratory and OmniPathology in October 2025.
- Indiana Animal Disease Diagnostic Laboratory at Purdue University selected PathFlow on January 20, 2026. The Purdue announcement describes that selection.
- Gestalt said it was recognized for a seventh consecutive year on the Inland Northwest 25+5 list in February 2026.
Gestalt’s website lists or references ARUP Laboratories, BioReference Laboratories, Northwell Health, Purdue University, Moffitt Cancer Center, Yale, Baptist Health South Florida, MaineHealth, OmniPathology, SAGIS Patient-Focused Diagnostics, Tulsa Medical Laboratory and other laboratory and pathology groups. These are company-reported customer or partner references. A logo or announcement does not, by itself, prove a paid production deployment, revenue level or clinical-performance result. Gestalt’s news page provides the company’s timeline.
What a potential buyer would need to evaluate
Integration and infrastructure
- Compatibility with existing whole-slide scanners.
- Bidirectional LIS and EHR exchange, including patient and case-identifier matching.
- Cloud versus on-premise deployment, bandwidth, storage, backup and disaster recovery.
- Viewer responsiveness for very large images and multi-site access.
AI governance and clinical boundaries
- Which functions are FDA-cleared, validated laboratory-developed tests or research use only.
- Whether algorithms are advisory or part of a regulated diagnostic workflow.
- Validation by tissue type, monitoring, version control, audit trails and responsibility when an AI suggestion conflicts with a pathologist’s interpretation.
Security and commercial terms
- HIPAA safeguards, encryption, access controls, logging, retention and uptime commitments.
- Implementation, training, change-management and data-migration requirements.
- Subscription, per-case, enterprise, storage and AI-module fees.
Gestalt does not publish public pricing in the reviewed material. Enterprise buyers should expect a quote-based process and request procurement documentation rather than relying solely on marketing claims.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Trade-offs and failure modes
Vendor neutrality versus integration effort
Supporting multiple scanners, LIS systems and AI tools can reduce hardware or algorithm lock-in. It can also require more interfaces, validation and operational governance than a single-vendor stack.
Cloud access versus control
Cloud deployment can simplify multi-site access and reduce local infrastructure. Buyers still need answers on data residency, network outages, cybersecurity, retention and long-term storage costs.
Best Value
- COMS Sensor Scanner: Equip with high-sensitive CMOS sensor, hand barcode scanner easily reads bar code from paper and screen, such as computer monitor, smartphone or tablets.
- Strong Recognition Capability: USB wired barcode reader can accurately read blurring, incomplete, support almost all 1D bar codes. 2D barcode: PDF417, MicroPDF417, Data Matrix, Maxicode, QR Code, Aztec, Hanxin, etc.
- Compatibility: Full compatible with Windows, Mac OS, Linux, plug the usb cable into your laptop, computer, cash register or POS, simple operation. The bar code scanner works with Quickbook, Word, Excel, Novell, and all common software.
- Supports Multi Languages: The scanner support 18 international keyboards: American Keyboard, Germany, France, Belgium, Finland, Sweden, Russia, Turkey, Portugal, England, Denmark, Norway, Spain, Italy, Japan, Poland, Romania, Hungary.
- Widely Use Range: The Sumicor 2m wired barcode scanner with holder is widely used in supermarket, restaurant, retail stores, warehouse, library, drugstore, Logistics for for file management, inventory tracking and POS(point of sale), etc.
AI breadth versus validation complexity
A platform that hosts multiple algorithms gives laboratories choice, but each algorithm may require separate clinical validation, regulatory review and monitoring. Digitizing a slide can improve access and collaboration without proving better diagnostic accuracy.
Practical failure modes include incomplete scans, image-quality problems, network latency, incorrect LIS identifiers, poorly calibrated algorithms, alert fatigue, staff resistance, unexpected storage growth and unclear accountability for conflicting recommendations.
Competitive context and what remains unproven
Gestalt operates in a crowded ecosystem that includes scanner manufacturers, enterprise pathology-image vendors, AI algorithm companies, cloud platforms and laboratory-information-system suppliers. A serious buyer may compare PathFlow with PathPresenter, Paige, Leica Biosystems/Aperio, Philips Digital & Computational Pathology and Sectra. These products are not identical substitutes, and public pricing was not established for the comparison set.
The financing and subsequent announcements do not establish Gestalt’s valuation, revenue, customer count, public pricing, independent clinical-outcome data or a Gestalt-specific FDA clearance. They do establish capital for scaling a vendor-neutral workflow platform and expanding its AI ecosystem.
The Tool Desk
Outbyte Driver Updater FREEScan for outdated or missing drivers - takes under a minuteDriver Scan →Outbyte PC Repair FREEClear out junk files and repair common Windows errorsFree Scan →The Bottom Line
Gestalt Diagnostics’ $7.5 million Series A is meaningful infrastructure and commercialization funding for PathFlow, a digital-pathology workflow platform that incorporates AI. Its next proof points are adoption, reliable integrations, regulatory progress and independently measured workflow or diagnostic benefits—not the financing announcement alone.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
